Search Results - "Vigorito, A.C"

Relevance of Cytogenetics in Myelodysplastic Syndrome (MDS) in the Assessment of Hematopoietic Stem Cell Transplantation (HSCT) Survival by Duarte, F, Santos, T.E.J, Korhnblitt, L, Correa, W, Basquiera, A.L, Belli, C, Funke, V.A.M, Colturato, V.A.R, Hamerschlak, N, Vilela, N.C, Silva, R.L, Vigorito, A.C, Paz, A, Stevenazzi, M, Velloso, E, Neto, A.E. Hallack, Bettarello, G, Lopes, L.F, Soares, R.D.D.A, Lemes, R.P.G

Get full text

Results of the Latin-American Registry of Bone Marrow Transplantation (BMT) in Myelodysplastic Syndrome (MDS) by Duarte, F, Santos, T.E.J, Funke, V.A.M, Colturato, V.A.R.C, Hamerschlak, N, Vilela, N.C.V, Lopes, L.F, Macedo, M.C.M.A, Vigorito, A.C, Soares, R.D.D.A, Paz, A, Stevenazzi, M, Diaz, L, Neto, A. E.H.N, Bettarello, G, Gusmao, B.M, Salvino, M.A, Calixto, R.F, Velloso, E.D.R.P, Lemes, R.P.G

Get full text

PO016 Secondary leukemia in a patient with multiple myeloma treated by a standard protocol of chemotherapy and autologous bone marrow transplantation by Lorand-Metze, I, Kameo, R.E, Oliveira-Duarte, G, Fattori, A, Aranha, F.P, Vigorito, A.C, de Souza, C.A

Get full text

Immature reticulocytes as an early predictor of engraftment in autologous and allogeneic bone marrow transplantation by Noronha, J.F.A., De Souza, C.A., Vigorito, A.C., Aranha, F.J.P., Zulli, R., Miranda, E.C.M., Grotto, H.Z.W.

“…Summary The purpose of this study was to evaluate reticulocyte parameters by means of flow cytometric reticulocyte counting in a group of patients who had…”
Get full text

Amifostine (WR-2721), a cytoprotective agent during high-dose cyclophosphamide treatment of non-Hodgkin's lymphomas: a phase II study by De Souza, C A, Santini, G, Marino, G, Nati, S, Congiu, A M, Vigorito, A C, Damasio, E

“…Clinical trials indicate that amifostine may confer protection on various normal tissues without attenuating anti-tumor response. When administered prior to…”
Get full text

PRINCIPAL ACTIONS OF THE MYELODYSPLASTIC SYNDROME HSCT AMERICAN LATIN REGISTRY by Duarte, F.B., Santos, T.E., Funke, V., Colturato, V.A.R., Hamerschlak, N., Villela, N., Macedo, M.C.M.A., Vigorito, A.C., Soares, R.D.A., Paz, A., Diaz, L., Stevenazzi, M., Neto, A.E. Hallack, Bettarello, G., Gusmão, B.M., Salvino, M.A., Calixto, R.F., Moreira, M.C.R., Teixeira, G.M., Silva, C.C., Paton, E.J.A., Rocha, V., Enrico, A., Bonfim, C., Chiattone, R., Simioni, A.J., Arrais, C., Coelho, E.O.D.M.

Get full text

Establishing A Data Management At HSCT Unit In the University Of Campinas by Miranda, E.C.M, Vigorito, A.C, De Souza, C.A

Get full text

The availability of full match sibling donors and feasibility of allogeneic bone marrow transplantation in Brazil by Eid, K A B, Miranda, E C M, Vigorito, A C, Aranha, F J P, Oliveira, G B, De Souza, C A

“…The feasibility of allogeneic bone marrow transplantation (alloBMT) in a developing country has not yet been demonstrated. Many adverse factors including…”
Get full text

Hematopoietic Cell Transplantation Co-Morbidity Index (HCT-CI) to Predict Non Relapse Mortality (NRM) After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) by Colella, M.P, Miranda, E.C.M, Aranha, F.J.P, Fernandes-Junior, V.C.A, Medina, S.M, de Souza, C.A, Vigorito, A.C

Get full text

Pre and Post HSCT Evaluation Indicates Reduction of Physical and Functional Performance Due to Transplant by De Souza, C.V, Miranda, E.C.M, De Souza, C.A, Aranha, F.J.P, Vigorito, A.C

Get full text

Genotyping Of Human Cytomegalovirus (HCMV) In Allogeneic Hematopoietic Stem Cell Transplant Recipients by Dieamant, D.C, Bonon, S.H.A, Murakami, M.M, Costa, S.C.B, Vigorito, A.C

Get full text

High-dose cyclophosphamide followed by autologous peripheral blood progenitor cell transplantation improves the salvage treatment for persistent or sensitive relapsed malignant lymphoma by Baldissera, R C, Aranha, J F P, Oliveira, G B, Vigorito, A C, Eid, K A B, Miranda, E C M, De Souza, C A

“…Trials have demonstrated that high-dose escalation followed by autologous transplantation can promote better long-term survival as salvage treatment in…”
Get full text

Genotyping of Human Cytomegalovirus (Hcmv) Glycoprotein B (Gb) in Hematopoietic Stem Cell Transplant Recipients With Active HCMV infection: Impact of gB Genotypes on the Patient's Outcome by Dieamant, D.C, Bonon, S.H.A, Murakami, M.M, Aranha, F.J.P, Duarte, G.O, Fernandes, V.C.A, de Souza, C, Costa, S.C.B, Vigorito, A.C

Get full text

Correlation of mixed lymphocyte culture with chronic graft-versus-host disease following allogeneic stem cell transplantation by Visentainer, J E L, Lieber, S R, Persoli, L B L, de Souza Lima, S C B, Vigorito, A C, Aranha, F J P, Eid, K A B, Oliveira, G B, Miranda, E C M, de Souza, C A

“…The purpose of the present study was to evaluate the mixed lymphocyte culture as a predictive assay of acute and chronic graft-versus-host disease (GVHD). We…”
Get full text

Association Between HLA-E Polymorphism And Severe Fungal Infections After Hematopoietic Stem Cell Transplantation by Testa, G.V, Tamouza, R, Busson, M, Fortier, C, Marques, S.B, Charron, D, Vigorito, A.C

Get full text

Brazilian Workshop on Diagnosis, Classification and Assessment of Severity of Chronic Graft-Versus-Host Disease According to the Criteria of the National institutes of Health by Bouzas, L.F.S, de Cassia Tavares, R.B, Silva, M.M, Moreira, M.C.R, Vigorito, A.C, Funke, V.M, Mauad, M.A, Correa, M.E.P, Souza, C.V, Nunes, E, Ferrari, A, Paixao, A, Martins, T, Pallottino, E, Flowers, M.E

Get full text

A Survey of Chronic GVHD and Other Outcomes – a Snapshot of Brazilian Allogeneic Hematopoietic Cell Transplantation (HCT) Centers by Funke, V.A.M, Bouzas, L.F, Dulley, F, Vigorito, A.C, Moreira, M.-C.R, Mauad, M, Chiattone, R, Salvador, J, Hamerschlak, N, Paton, E, Gouveia, R, Silla, L, Coelho, E, Teixeira, G, Tavares, R, Miranda, E, Correa, E.E.P, de Souza, C.V, Matos, M, Navarro, G, Flowers, M.E.D

Get full text

68 - Results of the Latin-American Registry of Bone Marrow Transplantation (BMT) in Myelodysplastic Syndrome (MDS) by Duarte, F., Santos, T.E.J., Funke, V.A.M., Colturato, V.A.R.C., Hamerschlak, N., Vilela, N.C.V., Lopes, L.F., Macedo, M.C.M.A., Vigorito, A.C., Soares, R.D.D.A., Paz, A., Stevenazzi, M., Diaz, L., Neto, A. E.H.N., Bettarello, G., Gusmao, B.M., Salvino, M.A., Calixto, R.F., Velloso, E.D.R.P., Lemes, R.P.G.

Get full text

243 - Relevance of Cytogenetics in Myelodysplastic Syndrome (MDS) in the Assessment of Hematopoietic Stem Cell Transplantation (HSCT) Survival by Duarte, F., Santos, T.E.J., Korhnblitt, L., Correa, W., Basquiera, A.L., Belli, C., Funke, V.A.M., Colturato, V.A.R., Hamerschlak, N., Vilela, N.C., Silva, R.L., Vigorito, A.C., Paz, A., Stevenazzi, M., Velloso, E., Neto, A.E. Hallack, Bettarello, G., Lopes, L.F., Soares, R.D.D.A., Lemes, R.P.G.

Get full text

Feasibility Of NIH Consensus Criteria For Chronic Graft-Versus-Host Disease (GVHD): Successful Efforts In Establishing A Multicenter Brazil-Seattle Collaborative Consortium by Vigorito, A.C, Miranda, E.C.M, Bouzas, L.F.S, Moreira, M.R, Silva, M.M, Tavares, R.C.B, Correa, M.P, Funke, V.A.M, Nunes, E.C, Colturato, V.R, Pedro, A, de Sousa, M.P, Mauad, M, Camacho, K.G, de Souza, C.V, Lee, S.J, Flowers, M.E.D

Get full text